DALI Medical’s SAN®Light Passive Safety Needle coupled with a novel drug product, enabling user-friendly administration
DALI Medical Devices, an innovative developer and distributor of drug delivery devices, today announced the first commercial implementation of its SAN-Light passive safety needle.
DALI’s novel safety needle - SAN®Light - launched with ADVANZ PHARMA’s MYTOLAC®/MYRELEZ® drug product. (PRNewsfoto/DALI Medical Devices Ltd.)
SAN-Light was chosen to be used with ADVANZ PHARMA's MYTOLAC®/MYRELEZ® - the first generic lanreotide drug product for the treatment of acromegaly and gastroenteropancreatic neuroendocrine tumors (GEP-NETs), which to date has been launched in two EU markets. ADVANZ's product incorporates a prefilled syringe and a special version of SAN-Light needle that was customized to fit to the drug parameters and users' needs. SAN-Light was selected for the product in large part because of its user-friendly design and easy customization to fit the syringe.
SAN-Light is a unique, single-use sterile hypodermic safety needle that is compatible with any Luer-lock syringe for subcutaneous or intramuscular drug administration. It is part of DALI's SAN® (Safe Auto Needle) family of safety injectable drug delivery devices, all of which enable a more safe and easy-to-use injecting experience for a wide range of formulations.
The SAN-Light enables an enhanced experience for patients and the people who administer the injections, whether they are healthcare professionals, family members or patients. The automatically activated (passive) needle shield reduces needle-stick injuries, and the partially hidden needle alleviates needle anxiety. Additional design features further facilitate injections.
"We are delighted to have worked with ADVANZ PHARMA on this important, unique solution," said David Daily, CEO of DALI. "It's a win-win collaboration that helps patients and enhances the commercialization of ADVANZ PHARMA's drug product by enabling a better experience and ease of administration."
About DALI Medical Devices Ltd.
DALI has been developing drug delivery devices from concept to commercialisation for pharmaceutical and medical device companies since 2003. DALI offers patient-centric solutions for both healthcare professionals and for self-injection at home. The addition of a DALI injector boosts the value of a medication for patients, enabling reduced perception of pain, less anxiety, and better adherence to treatment plans. www.dalimed.com
Related News
-
Sponsored Content CPHI Podcast Series: Ursatec – celebrating 30 years of pioneering preservative free
In the latest episode of the CPHI Podcast Series, Digital Editor Lucy Chard spoke with Dominik Rocchi of Ursatec. -
Sponsored Content How healthcare trends inform dosage forms
Capsules encompass one of the most popular solid oral dosage forms for pharmaceutical products, with the global empty capsule market predicted to rise to USD $3.7 billion by 2026. The growth in the capsule market can be partly attributed to the many op... -
Sponsored Content 2023 Pharma Trend Outlook: Innovation, Resilience, and Pharma 4.0
Download our 2023 Pharma Trends Outlook report to discover the trends set to shape the pharmaceutical landscape in the new year, with expert opinions and insight from across the pharmaceutical value chain. -
Sponsored Content CPHI Podcast Series: Key Considerations in Selecting the Right CMO Partner
In this month's episode we hear from Jayna Blake, Senior Project Manager for Technical Programs at Baxter BioPharma Solutions, on key considerations for successful CMO selection. -
Sponsored Content PharmaNutra announces new technology to combat iron deficiency
This oral solution allows for high iron absorption while minimising digestive issues -
Sponsored Content Size doesn’t matter: How smaller deals are shaping healthcare M&A
Several mega-deals have made a splash in the pharma and life sciences industries over recent years – from AstraZeneca’s acquisition of Alexion for $39 billion to Gilead Sciences’ $21 billion purchase of Immunomedics. With am... -
Sponsored Content Rise in home-based healthcare shaping pharma packaging and drug delivery
The pharma packaging and drug delivery industry has long been synonymous with rapid innovation. As medicine advances and patient needs change, so too should drug packaging and devices. This has been particularly evident during the pandem... -
Sponsored Content Biologics earmarked as opportunity in pharma packaging and drug delivery
The pharma packaging and drug delivery industry has gone through many evolutions, most notably to meet the challenges posed by the COVID-19 pandemic over the last two years. Disruptions to global supply chains posed a major issue, combined with a sharp...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance